Skip to main content

Table 2 Biochemistry analyses in diabetic patients with acute hyperglycemia (Group A) at baseline (upon hospital admission), second (after euglycemia was achieved, 72 h) and third examination (after 3 months), in diabetic patients with euglycemia (Group B) and in healthy controls (Group C)

From: Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography

 

Group A

p value*

Group B

Group C

p value**

Upon hospital admission

Second examination

Third examination

Blood glucose (mmol/l)

22.5 ± 1.1a

5.5 ± 0.1

7.2 ± 0.2

 < 0.001

5.8 ± 0.2

5.1 ± 0.1

 < 0.001

HbA1c (%)

11.5 ± 0.3

NA

7.9 ± 0.2

 < 0.001

6.1 ± 0.1

5.0 ± 0.1

 < 0.001

Total Ch (mmol/l)

6.2 ± 0.4

5.4 ± 0.2

5.1 ± 0.2

0.002

4.8 ± 0.2

5.1 ± 0.2

0.055

HDL-Ch (mmol/l)

1.2 ± 0.1

1.1 ± 0.1

1.3 ± 0.1

0.053

1.4 ± 0.1

1.6 ± 0.1

 < 0.001

LDL-Ch (mmol/l)

2.9 ± 0.2

3.0 ± 0.1

2.8 ± 0.1

0.039

2.7 ± 0.1

2.8 ± 0.2

0.747

Triglyceride (mmol/l)

6.4 ± 1.4

3.2 ± 0.4

2.3 ± 0.2

0.003

1.9 ± 0.2

1.5 ± 0.3

0.036

Troponin (ng/l)

8.9 ± 0.8

6.8 ± 0.5

6.1 ± 0.6

0.013

8.2 ± 0.7

7.6 ± 1.1

0.652

NT-proBNP (pg/ml)

25.0 (28.5)b

14.0 (17.0)

15.0 (20.0)

 < 0.001

21.5 (41.5)

19.0 (25.8)

0.597

  1. Ch cholesterol, NT-proBNP N-terminal pro b-type natriuretic peptide
  2. * p—Repeated measures ANOVA (upon hospital admission, second examination and third examination)
  3. ** p—One way ANOVA between Group A (upon hospital admission), Group B and Group C. Post Hoc Bonferroni test between the groups is described in the text
  4. aData are presented as mean ± SE or as bmedian